Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 09 - 08 save search
Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-102 for the Treatment of Rett Syndrome
Published: 2021-09-08 (Crawled : 21:00) - biospace.com/
TSHA | $2.355 -6.92% -7.43% 790K
|
Health Technology
|
| O: -0.32%
H: 1.3%
C: -7.81%
treatment gene therapies gene therapy syndros therapy rett syndrome tsha-102
FILING DEADLINE FOR ATIP INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ATI Physical Therapy Inc.
Published: 2021-09-08 (Crawled : 19:00) - prnewswire.com
ATIP | News | $4.06 0.24% 0.0% 980
|
Manufacturing
|
| O: 0.0%
H: 4.5%
C: 0.75%
therapy
Dr. Benjamin Musher to Chair Phase 1-2 Study Evaluating XBiotech’s Natrunix™ Anti-Cancer Therapy in Pancreatic Cancer
Published: 2021-09-08 (Crawled : 14:00) - biospace.com/
XBIT | $8.075 -1.28% -1.3% 65K
|
Health Technology
|
| O: 0.25%
H: 0.89%
C: -0.44%
phase 1 therapy cancer biotech iot pancreatic phase 2 phase 3 pancreas
LHC Group to acquire home health, hospice and therapy assets in 22 states from HCA Healthcare and Brookdale Health Care Services Venture
Published: 2021-09-08 (Crawled : 13:00) - lhcgroup.com
BKD | $6.75 -2.6% 0.0% 1.7M
|
Health Services
|
| O: -0.58%
H: 0.58%
C: -1.9%
LHCG | $169.81 0.47% -0.03% 0
|
Health Services
|
| O: 0.14%
H: 3.17%
C: 2.91%
therapy health
HUTCHMED and AstraZeneca Initiate SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
Published: 2021-09-08 (Crawled : 11:00) - globenewswire.com
HCM | $18.405 0.85% 0.84% 58K
|
Health Technology
|
| O: -2.29%
H: 1.34%
C: 1.29%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.85%
H: 0.17%
C: -0.42%
lung cancer china therapy cancer trial
Global Embolotherapy Market to Surpass $6,447.1 Million Revenue by 2030 says P&S Intelligence
Published: 2021-09-08 (Crawled : 09:00) - prnewswire.com
SYK | $336.85 0.58% 0.0% 1.5M
|
Health Technology
|
| O: -0.09%
H: 0.9%
C: 0.6%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: -0.11%
H: 0.94%
C: 0.56%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.41%
H: 0.79%
C: 0.16%
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: -0.16%
H: 1.71%
C: 1.07%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.13%
H: 0.75%
C: 0.39%
therapy
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.